Green Stock News Green Stock News

TILRAY NASDAQTLRY STOCK QUOTE

https://www.tilray.com/

LATEST NEWS FROM TILRAY

January 20, 2022
Boost Your 2022 Wellness Routine With Manitoba Harvest
January 10, 2022
Dara Redler to Join H&R Block as new Chief Legal Officer
January 10, 2022
Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results
December 20, 2021
Tilray to Announce Second Quarter Fiscal 2022 Financial Results on January 10, 2022
December 8, 2021
Tilray Strengthens Strategic Position in the U.S. with Acquisition of Breckenridge Distillery
December 2, 2021
Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays
December 2, 2021
Launch of Tilray’s Fast-Acting Oral Strips Highlights Commitment to Medical Cannabis Innovation and Patient Care
November 22, 2021
Tilray Hosts 2021 Annual Meeting of Shareholders
November 16, 2021
Tilray to Webcast Annual Meeting of Stockholders on November 22, 2021
November 11, 2021
Tilray to Participate in Two Jefferies Investor Conferences
November 4, 2021
Tilray’s Sweetwater Brand Enters Spirits Category Through New Ready-To-Drink Cocktail Now Available in the United States
October 26, 2021
Tilray Expands Medical Cannabis Footprint in Europe
October 20, 2021
Tilray Signs Distribution Agreement With Great North Distributors for Adult-Use Cannabis Sales Across Canada
October 19, 2021
Tilray Strengthens Leadership Position in Canada
October 7, 2021
Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results
September 23, 2021
Tilray to Announce First Quarter Fiscal 2022 Financial Results on October 7, 2021
September 10, 2021
Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting
September 8, 2021
Tilray to Participate in Barclays Global Consumer Staples Conference on September 10th, 2021
August 26, 2021
Tilray Chairman and CEO, Irwin D. Simon, Sends Shareholder Letter Mapping out $4B Revenue Plan
August 19, 2021
Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021
August 17, 2021
Tilray Acquires Majority Position in Amended MedMen Convertible Notes
August 5, 2021
Tilray Launches New Medical Cannabis Edibles in Canada
July 29, 2021
Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021
July 28, 2021
Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results
July 27, 2021
Manitoba Harvest Announces New Research Partnership to Drive Innovation in Hemp and Pea Protein
July 27, 2021
New partnership to develop pea and hemp varieties for ingredient processing
July 22, 2021
Growth Oriented Cannabis Companies Are Your Best Bet; Don't Bet On The Government To Legalize Weed
July 21, 2021
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Tilray Shareholders Vote “FOR” All Proposals at Tilray’s Upcoming Special Meeting
July 15, 2021
Tilray to Announce Fourth Quarter and Fiscal 2021 Financial Results on July 28, 2021
July 12, 2021
Leading Independent Proxy Advisory Firm ISS Recommends Tilray Shareholders Vote “FOR” All Proposals at Tilray’s Upcoming Special Meeting
July 7, 2021
Tilray’s Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of Medical Cannabis Grown in Germany
June 30, 2021
Tilray Introduces Its First Cross-brand Product Collaboration and Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S.
June 29, 2021
Tilray Asks Stockholders to Support Key Initiatives to Drive Strategic Growth and Strengthen Stockholder Rights
June 10, 2021
Four Cannabis Stocks for the Summer of 2021
June 8, 2021
Tilray Announces Launch of New Medical Cannabis Brand, Symbios
May 25, 2021
Tilray to Webcast Fireside Chats From Two Investor Conferences in June
May 13, 2021
Tilray to Participate in BMO Capital Markets Investor Conference
May 5, 2021
Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”
May 3, 2021
Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader
April 27, 2021
Tilray Named to Time’s Inaugural List of the Time100 Most Influential Companies
April 16, 2021
Tilray Board of Directors Announces Approval of Amendment to Company’s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement
April 15, 2021
Special Meeting of Tilray, Inc. Stockholders Adjourned to April 30, 2021 at 11:00 a.m. Eastern Time
April 12, 2021
MAKE YOUR VOTE COUNT!: Tilray Reminds Shareholders to Vote FOR the Proposed Business Combination With Aphria Inc.
April 5, 2021
Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend Shareholders Vote FOR the Proposed Aphria and Tilray Business Combination
April 5, 2021
Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
March 15, 2021
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
March 10, 2021
Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand
February 17, 2021
Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results
February 12, 2021
Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17, 2021
February 9, 2021
Tilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom
February 4, 2021
Tilray® Exports First Shipment of Medical Cannabis to Spain
February 1, 2021
Tilray® Receives the First and Only Market Authorization to Offer Medical Cannabis Products in Portugal
January 26, 2021
Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France